ANDA 64021, held by Apothecon. Tobramycin Sulfate.
As of Nov 16, 2026, ANDA 64021 (Tobramycin Sulfate), held by Apothecon, was first approved by FDA on May 31, 1994, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 31, 1994 | Original application | Approved | None posted |
| Tobramycin SulfateEQ 10MG BASE/ML · injectable;injection | Tobramycin Sulfate | Discontinued |
| Tobramycin SulfateEQ 40MG BASE/ML · injectable;injection | Tobramycin Sulfate | Discontinued |
| Aug 6, 2002 | Supplement 4Manufacturing | Approved | None posted |
| Aug 26, 1996 | Supplement 2Manufacturing | Approved | None posted |
| Mar 10, 1995 | Supplement 1Manufacturing | Approved | None posted |
| May 31, 1994 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters